Art

J-GLOBAL ID：201902231588103302   Reference number：19A1298715

Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance

日本における非典型溶血性-尿毒症症候群成人患者に対するエクリズマブの安全性および有効性:市販後調査の中間分析

Author (15)： Kato Hideki (Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan) ,  Miyakawa Yoshitaka (Department of General Internal Medicine, Thrombosis and Hemostasis Center, Saitama Medical University, Saitama, Japan) ,  Hidaka Yoshihiko (Clinical Division of Pediatrics, Shinshu University Hospital, Matsumoto, Nagano, Japan) ,  Inoue Norimitsu (Department of Tumor Immunology, Osaka International Cancer Institute, Osaka, Japan) ,  Ito Shuichi (Department of Pediatrics, Graduate School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan) ,  Kagami Shoji (Department of Pediatrics, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan) ,  Kaname Shinya (Department of Nephrology and Rheumatology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan) ,  Matsumoto Masanori (Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Nara, Japan) ,  Mizuno Masashi (Renal Replacement Therapy, Division of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan) ,  Matsuda Takahisa (Alexion Pharma GK, Tokyo, Japan) ,  Shimono Akihiko (Alexion Pharma GK, Tokyo, Japan) ,  Maruyama Shoichi (Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan) ,  Fujimura Yoshihiro (Japanese Red Cross Kinki Block Blood Center, Ibaraki, Osaka, Japan) ,  Nangaku Masaomi (Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan) ,  Okada Hirokazu (Department of Nephrology, Saitama Medical University, Saitama, Japan)
Material： Clinical and Experimental Nephrology (Web)
Volume： 23  Issue： 1  Page： 65-75  Publication year： 2019 
JST Material Number： U1582A  ISSN： 1342-1751  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *Thrombocytopenia ,...
Semi thesaurus term： *eculizumab ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1298715&from=J-GLOBAL&jstjournalNo=U1582A") }}

Author keywords (5)： Atypical hemolytic-uremic syndrome ,  Post-marketing surveillance ,  Complement ,  C5 inhibitor ,  Eculizumab

JST classification (3)： Drug therapy(=pharmacotherapy)for hematologic diseases in general  (GK05020P) ,  Drug therapy(=pharmacotherapy)for urogenital diseases  (GM05020V) ,  Clinical application of immunotherapeutic agents and blood preparations  (GW22020O)

Terms in the title (10)： 日本 ,  溶血 ,  尿毒症症候群 ,  成人 ,  患者 ,  エクリズマブ ,  安全性 ,  有効性 ,  市販後調査 ,  分析